Affluent Medical | WebDisclosure

Basculer en Français

11276	Companies
250575	Keywords
179213	Articles
136415	Press releases

Home
Companies
Affluent Medical

PRESS RELEASE

published on 09/11/2026 at 17:45, 1 month 23 days ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26.
Communiqué réglementaire du 11 sep 2026 : Nombre d'actions et de droits de vote pour Carvolix (FR0013333077). Carvolix, société de technologies médicales en France, se positionne comme un leader mondial dans le traitement du cœur et des AVC

Nombre D'actions Droits De Vote Leader Mondial Carvolix Société De Technologies Médicales
BRIEF

published on 09/09/2026 at 17:50, 1 month 25 days ago

Carvolix prépare le lancement européen de TAVIPILOT après dépôt réglementaire

Marquage CE Technologies Médicales Déploiement Européen Carvolix TAVIPILOT
BRIEF

published on 09/09/2026 at 17:50, 1 month 25 days ago

Carvolix fait progresser le logiciel TAVIPILOT vers un lancement européen

Marquage CE Carvolix Lancement Européen Logiciel TAVIPILOT Guidage Par IA
BRIEF

published on 09/09/2026 at 17:50, 1 month 25 days ago

Carvolix Advances TAVIPILOT Software Toward European Launch

CE Marking European Launch Carvolix TAVIPILOT Software AI-guidance
BRIEF

published on 09/09/2026 at 17:50, 1 month 25 days ago

Carvolix is preparing the European launch of TAVIPILOT following regulatory filing

Medical Technologies CE Marking European Deployment Carvolix TAVIPILOT
PRESS RELEASE

published on 09/09/2026 at 17:45, 1 month 25 days ago

Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking.
Carvolix takes key step toward commercial launch of TAVIPILOT Software in Europe with CE marking submission, targeting early 2027 launch. Positive feedback from initial US commercial contract at Rush University Medical Center

Europe Commercial Launch CE Marking Carvolix TAVIPILOT Software
PRESS RELEASE

published on 09/09/2026 at 17:45, 1 month 25 days ago

Carvolix amorce son déploiement commercial en Europe suite au dépôt du dossier réglementaire du logiciel TAVIPILOT pour le marquage CE.
Carvolix amorce son déploiement commercial en Europe suite au dépôt du dossier réglementaire du logiciel TAVIPILOT pour le marquage CE. Lancement prévu début 2027

Europe Marquage CE Déploiement Commercial Carvolix TAVIPILOT
BRIEF

published on 08/24/2026 at 18:35, 2 months 11 days ago

Coopération médicale franco-saoudienne : lancement du programme SAF-MD

Intelligence Artificielle Cardiologie Coopération Médicale SAF-MD France-Arabie Saoudite
BRIEF

published on 08/24/2026 at 18:35, 2 months 11 days ago

Coopération médicale franco-saoudienne : lancement du programme SAF-MD

IA Et Robotique Vision Saoudienne 2030 Coopération Médicale Formation En Cardiologie Expansion MedTech
BRIEF

published on 08/24/2026 at 18:35, 2 months 11 days ago

Carvolix Expands with New Saudi Manufacturing Facility

Medical Manufacturing MedTech Expansion Saudi-French Cooperation AI-guided Robotics Heart Valve Replacement

Accesswire

Published on 11/04/2026 at 23:10, 30 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 40 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 40 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 1 hour 25 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 1 hour 35 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/04/2026 at 19:41, 3 hours 59 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 4 hours 15 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 4 hours 57 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 5 hours 35 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 17:40, 6 hours ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.26.

Les Echos

Published on 11/04/2026 at 18:00, 5 hours 40 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 5 hours 40 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 5 hours 55 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 5 hours 55 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 5 hours 56 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE